Record results mark 18th consecutive quarter of revenue growth
* Product revenues increased 29% to a record $199.7 million
* Masimo SET pulse oximeter units increase 20% to 116,300 units
IRVINE, Calif., Feb. 26 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motion & Low Perfusion pulse oximetry, today announced its financial results for both the quarter and year ended December 29, 2007.
For the fiscal fourth quarter, Masimo reported product revenues of $55.2 million representing a 29% increase over $42.9 million for the fourth quarter of 2006. Including royalty revenues, Masimo reported total fourth quarter revenues of $69.3 million compared to $61.6 million for the fourth quarter of 2006. Net income for the quarter was $12.1 million representing $0.20 earnings per common share, including $0.02 per common share relating to a year-to-date tax benefit recorded in the fourth quarter. Masimo also reported that it shipped 29,400 Masimo SET and Masimo Rainbow SET oximetry units, excluding handheld units, during the fourth quarter of 2007, up 10% from 26,700 in the comparable prior year period, resulting in a new estimated worldwide installed base of 470,000 Masimo SET pulse oximeters.
For the year ended December 29, 2007, Masimo's product revenues were
$199.7 million, up 29% from $155.1 million in 2006. Including royalty
revenues, Masimo's total revenues were $256.3 million for the year ended
December 29, 2007, up from $224.3 million in 2006. In the year ended
December 29, 2007, Masimo shipped 116,300 Masimo SET and Masimo Rainbow SET
pulse oximeter units, excluding handheld pulse oximete
|SOURCE Masimo Corporation|
Copyright©2008 PR Newswire.
All rights reserved